Kolexia
Danielou-Lazareth Anne Hématologie
Danielou-Lazareth Anne
Hématologie
Hôpital Lyon Sud
Pierre-Bénite, France
53 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Myélome multiple Lymphome B diffus à grandes cellules Paraprotéinémies Lymphome malin non hodgkinien Colique néphrétique Syndrome POEMS Calculs

Collaborateurs

Voir plus
Karlin Lionel
Karlin Lionel
Hôpital Lyon Sud, Pierre-Bénite, France
Ghesquieres Herve
Ghesquieres Herve
Hôpital Lyon Sud, Pierre-Bénite, France
Sesques Pierre
Sesques Pierre
Hôpital Lyon Sud, Pierre-Bénite, France
Bachy Emmanuel
Bachy Emmanuel
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Sanofi
3 collaboration(s)
Dernière en 2023
BMS
2 collaboration(s)
Dernière en 2023
Inter-View Partners France
2 collaboration(s)
Dernière en 2020
Janssen
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): Update of the IFM Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Skeletal Muscle Index, As a Measure of Muscle Mass, Is a Significant Prognostic Factor for Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
Sudden-onset painful eruption of the hands: A cutaneous chimeric antigen receptor T-cell therapy reaction.
JAAD case reports   26 août 2023
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood advances   06 mars 2023
Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas.
Leukemia & lymphoma   27 décembre 2022
Outcome in Multiple Myeloma Patients Treated in the Era of Modern Therapies Who Were Admitted to Intensive Care: A Retrospective Analysis from a Teaching Hospital between 2014 and 2019
Annual Meeting Abstracts 2022   15 novembre 2022
Evaluation of Participation and Recruitment Bias in a Prospective Real-Life Multicentric Cohort « Real World Data in Lymphoma and Survival in Adults » (REALYSA study) for Newly Diagnosed Lymphoma Patients over One Year in a Hematology Department of Teaching Hospital
Annual Meeting Abstracts 2022   15 novembre 2022
French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): An IFM Study from the Descar-T Registry
Annual Meeting Abstracts 2022   15 novembre 2022
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study.
Leukemia & lymphoma   31 octobre 2021
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
Blood advances   13 septembre 2021